Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19
{{output}}
Patients with sepsis display increased concentrations of sTREM-1 (soluble Triggering Receptor Expressed on Myeloid cells 1), and a phase II clinical trial focusing on TREM-1 modulation is ongoing. We investigated whether sTREM-1 circulating concentrations are ... ...
